These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22990092)

  • 21. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
    Veldhuis JD; Anderson SM; Kok P; Iranmanesh A; Frystyk J; Ørskov H; Keenan DM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1312-8. PubMed ID: 15001627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone.
    Veldhuis JD; Iranmanesh A; Mielke K; Miles JM; Carpenter PC; Bowers CY
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2441-6. PubMed ID: 16537682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.
    Veldhuis JD; Erickson D; Miles JM; Bowers CY
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1158-65. PubMed ID: 21467302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
    Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
    Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
    J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women.
    Kok P; Paulo RC; Cosma M; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4020-6. PubMed ID: 18611978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY; Granda-Ayala R
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.
    Soares-Welch C; Farhy L; Mielke KL; Mahmud FH; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2225-32. PubMed ID: 15634714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L; Rolla M; Arvat E; Belliti D; Valetto MR; Ferdeghini M; Ghigo E; Müller EE
    Biol Psychiatry; 1999 Feb; 45(3):334-9. PubMed ID: 10023511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji A; Miles JM; Paulo R; Cosma M; Soares-Welch C
    J Clin Endocrinol Metab; 2009 Jan; 94(1):246-54. PubMed ID: 18984660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release.
    Friend K; Iranmanesh A; Login IS; Veldhuis JD
    Eur J Endocrinol; 1997 Oct; 137(4):377-86. PubMed ID: 9368506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.